Connect with us
ARTEMISMED

Artemis Medicare Services Limited (ARTEMISMED) Stock Analysis

Artemis Medicare Services Limited operates the Artemis chain of multi-specialty hospitals in North India. It provides tertiary care in cardiology, oncology, orthopedics, and other specialties. The company is backed by private equity and focuses on premium healthcare delivery. It is a listed hospital stock.

₹308.40
+2.39% 1W  |  +25.90% 52W
Market Cap
–
P/E Ratio
134.7
52W High
₹378.8
52W Low
₹203.3
Div. Yield
0%
Beta
0.4
50 DMA
₹320.1
200 DMA
₹273.9
Profit Margin
10%
Inst. Own.
1.1%
Trendline Analysis
⚠️ BREAKDOWN₹391.1₹355.4₹319.7₹284₹248.313 May22 Jun29 Jul11 Sep09 Nov1.9Cr
Fundamentals
Profit & Loss
MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales225219225223241232240255275272279287311
YoY Sales growth+20%+17%+15%+7%+7%+6%+7%+14%+14%+17%+16%+13%+13%
Expenses191186187187199195204214224228228231256
Operating Profit34333836423736415145525655
OPM %15%15%17%16%18%16%15%16%18%16%18%20%18%
Other Income22247912784858
Interest8898888777667
Depreciation10101111111112111212131314
Profit before tax19162022312729303930404341
Tax %28%29%29%24%28%23%20%29%24%25%25%26%24%
Net Profit14121417222123213022303131
EPS in Rs1.000.851.041.221.621.501.671.532.161.411.901.981.96
Growth — CAGR
Metric3Y5Y10Y
Revenue CAGR14.0%22.0%–
Profit CAGR41.0%77.0%–
Shareholding Pattern
Promoters58.39%
FIIs12.45%
DIIs1.91%
Public21.07%
ARTEMISMED
Holdings Analysis
Key strengths & risk signals
58
Overall
42
Fundamental
75
Technical
Risks (3)
Cannot calculate PEG - insufficient growth data.
RECOVERY MODE! Current price (308.4) above 200-day but below 50-day.
WEAK MOMENTUM! Limited price growth - 2.4% (1 week), -1.5% (1 month), -1.6% (3 months).
Strengths (3)
BULLISH TREND! 50-day average (320.1) is above 200-day average (273.9) - positive signal.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 1,755,385 vs down days: 405,928. Ratio: 4.32x
LOW VOLATILITY! Beta of 0.40 - stable stock, less market risk.
Fundamental & Technical Analysis
58Overall
42Fundamental
75Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: 0% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
5/10
LOW MARGIN! 10.0% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 23.3% public ownership - balanced ownership structure.
Stability Index
5/10
Insufficient historical data for stability analysis.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (320.1) is above 200-day average (273.9) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (308.4) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
8/10
GOOD YEAR! Stock gained 25.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 1,755,385 vs down days: 405,928. Ratio: 4.32x
RSI
3/5
NEUTRAL! RSI at 42.8 - balanced momentum.
52W Range
3/5
MID RANGE! Trading at 59.9% of 52W range - neutral zone.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - 2.4% (1 week), -1.5% (1 month), -1.6% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.40 - stable stock, less market risk.
ARTEMISMED
Concall / Investor Presentation
Earnings call transcripts & AI summaries
QuarterConcallSummary
Q1FY272026-08-10Concall PDF
Q4FY262026-05-15Concall PDF
Q3FY262026-02-09Concall PDF
Q2FY262025-11-18Concall PDF

Peer Comparison

· · 1 stocks
Industry peers
StockPriceP/EProfit MarginRevenue CAGR 5YProfit CAGR 5Y52W ChangeStock StrengthTrendlineYoY ProfitQoQ ProfitYoY RevenueQoQ Revenue
ARTEMISMED₹308.40134.710.0%––+25.9%58 BREAKDOWN––––
Data from TradeAlone · Updated daily
Exit mobile version